Trial Profile
A trial assessing impact of pitavastatin on new-onset diabetes in patients with acute myocardial infarction enrolled in nation-wide Korean AMI registry (KAMIR)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin; Rosuvastatin
- Indications Myocardial infarction
- Focus Adverse reactions
- 08 Oct 2016 New trial record